InterMune Medical Chief Takes Stand Against Ex-Director
The U.S. Securities and Exchange Commission called InterMune's chief medical officer to testify in California federal court Tuesday about the regulatory approval path of its lung disease drug Esbriet, part of...To view the full article, register now.
Already a subscriber? Click here to view full article